Circadian clock gene plays role in memory formation

Alu­mis, an im­munol­o­gy drug de­vel­op­er on the cusp of Phase 3, will go pub­lic Fri­day in a small­er IPO than it orig­i­nal­ly pro­ject­ed. The Bay

Three nurses filed a class action lawsuit against the city and county of San Francisco last week, claiming they weren’t given legally mandated meal and

The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a